EN
HI
Beryl Drugs Chart
Beryl Drugs Share Key Metrics
Volume
173.00
Market Cap
10.65 CR
LTQ@LTP
8@20.30
ATP
20.37
Var Margin
30.78 %
Circuit Range
16.24-24.36
Delivery %
94.8 %
Value
3524.01
ASM/GSM
No
Market Lot
1
Summary
At 25 Mar, 2026 | 15:05, Beryl Drugs share price stands at ₹20.3, showing a 0.00% 0.00 for the day. The stock’s intraday movement has stayed between ₹20.20 and ₹21.40, while on a 52-week basis it has fluctuated from ₹15.92 to ₹30.00.
In terms of trading activity, Beryl Drugs has recorded a volume of 173 shares, with a market capitalisation of ₹5071700. The stock’s Average Traded Price (ATP) stands at ₹2037, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 8,2030. The stock operates within a circuit range of ₹16.24-24.36, with a Value of ₹3524.01. The Delivery Percentage for the day is 94.8%. Additionally, Beryl Drugs currently falls under the No framework, and trades with a market lot size of 1.
Beryl Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
58.66
Sector P/B
3.11
Sec. Div. Yield
0.6
Beryl Drugs Resistance and Support
Pivot 20.63
Resistance
First Resistance
21.06
Second Resistance
21.83
Third Resistance
22.26
Support
First Support
19.86
Second Support
19.43
Third Support
18.66
Beryl Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-08 | Quarterly Results |
Beryl Drugs News
Beryl Drugs Ltd - 524606 - DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015
Beryl Drugs' promoter Sudhir Sethi acquired 7,500 equity shares, representing 0.14% of the company. The transaction was conducted on-market on BSE on March 24, 2026.
Mar 25 2026 21:03:00
Beryl Drugs Ltd - 524606 - DISCLOSURE UNDER REGULATION 29(2) OF SEBI(SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011
Beryl Drugs promoter Sudhir Sethi acquired 7,500 equity shares through market transactions on March 24, 2026. This acquisition increased his stake in the company from 9.58% to 9.72%.
Mar 25 2026 21:03:00
Read More
About Beryl Drugs
NSE : 0
BSE : 524606
ISIN : INE415H01017
Beryl Drugs Management
| Name | Position |
|---|---|
| Mr. Sudhir Sethi | Chairman & Director |
| Mr. Sanjay Sethi | Managing Director |
Beryl Drugs Similar Stocks
Ishita Drugs & Industries Ltd.
77.89
0.00 (0.00%)
Emmessar Biotech & Nutrition Ltd.
23.98
0.00 (0.00%)
Deccan Health Care Ltd.
8.26
0.00 (0.00%)
Link Pharma Chem Ltd.
25.69
1.56 (6.46%)
Sharma East India Hospitals & Medical Research Ltd
98.80
-0.60 (0.60%)
Clinitech Laboratory Ltd.
35.00
0.00 (0.00%)
Norris Medicines Ltd.
12.56
-0.41 (3.16%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Beryl Drugs FAQs
The Buying Price of Beryl Drugs share is 20.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 58.66 & 3.11 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beryl Drugs is 10.65 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beryl Drugs share price is 30.00 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beryl Drugs belongs to the Healthcare sector.
